LEQEMBI is currently approved in 53 countries and regions and is under regulatory review in 7 countries. In August 2025, the US FDA approved LEQEMBI IQLIK 360 mg for weekly subcutaneous maintenance ...
BioArctic AB's (publ) (STO: BIOA B) partner Eisai announced today that the supplemental Biologics License Application (sBLA) for Leqembi Iqlik subcutaneous ...
BYD’s 2025 sales total of 26,122 units represents a staggering 446% increase over its 2024 performance and makes up 94.14% of ...
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and maintenance dosing for this progressive, relentless disease FDA acti ...
A strategic partnership between Canada and China will force U.S. automakers to rethink the product mix if they want to stay ...
The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and ...
The new IM5 is part of a new upmarket sub-brand for China's MG, but what can it offer?
This 7-day plan is set at 1,500 calories, with modifications for 1,800 and 2,000 calories. Each day provides at least 80 ...
Green beans and asparagus have similar nutritional profiles and both are high in vitamin K. See how they differ in other vitamins and their health benefits as part of a balanced diet.
Mercedes-Benz EQS SUV drive review: How much luxury is too much luxury?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results